Daylife Select
A point & click tool to create dynamic content portals. Learn More »
Editor's Picks
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
-
Now that the merger between Pfizer (PFE) and Wyeth (old ticker WYE) is completed, Pfizer’s compensation committee has agreed to reward two Pfizer executives for their “extraordinary efforts and…extraordinary contributions in addressing critical... Full Article at Footnoted
-
Not when thousands of employees lose their jobs. Give me a break! Full Article at Pharmalot
-
FILE - In this Jan, 25, 2009 photo, a bottle of Wyeth's Effexor is shown in New York. View Photo »
-
For their work on acquiring and planning to integrate Wyeth, Pfizer cfo and senior vp Frank D’Amelio (pictured left) and Ian Read, senior vp and group president of the biopharma biz (pictured below), were awarded big prizes. Full Article at Pharmalot
-
Pfizer (NYSE: PFE) closedits acquisition of Wyeth earlier this month and the EU signed off on Merck 's (NYSE: MRK) acquisition of Schering-Plough (NYSE: SGP) last week. The monster acquisitions will give Pfizer and Merck some serious heft. Full Article at Town Hall
-
Pfizer Inc. today reported a 26 percent jump in third-quarter profits as big cost cuts offset declining sales.New York-based Pfizer, which completed its $68 billion acquisition of Wyeth last week, said net income in its most recent quarter was $2.88... Full Article at Philadelphia Inquirer
-
In this Jan. 26, 2009 file photo, Jeffrey Kindler, left, chairman and CEO of Pfizer, and Bernard Poussot, president, chairman and CEO of Wyeth, speak at a news conference in New York. View Photo »
-
-
Pfizer reported higher third-quarter profit as aggressive cost-cutting helped offset unfavorable foreign currency exchange rates and declining sales of drugs, including those facing competition from cheaper generics. Full Article at CNBC
-
They plan within just 30 days — 60 days, tops — to announce what projects will stay in their research program and what gets cut. Full Article at San Francisco Chronicle
About Wyeth
Wikipedia
There are no results for this module. Edit this module to change the search term used to query Wikipedia
Related Photos
prev
next
-
AP Photo
FILE - In this Jan, 25, 2009 photo, a bottle of Wyeth's Effexor is shown in New York. Drugmaker Wyeth on Thursday posted a 13 percent jump in second-quarter profit, trouncing Wall Street forecasts, as cost cuts overcame lower sales due to generic competition and the strong dollar.
View Photo » -
AP Photo
In this Jan. 26, 2009 file photo, Jeffrey Kindler, left, chairman and CEO of Pfizer, and Bernard Poussot, president, chairman and CEO of Wyeth, speak at a news conference in New York.
View Photo » -
Reuters Pictures
Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, attend a news conference announcing the merger of the two companies in New York, January 26, 2009.
View Photo » -
Reuters Pictures
Jeffrey Kindler, (L) Chairman and CEO of Pfizer and Bernard Poussot, Chairman and CEO of Wyeth, speak during a press conference announcing the merger of the two companies in New York, January 26, 2009.
View Photo » -
Reuters Pictures
Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, attend a news conference announcing the merger of the two companies in New York, January 26, 2009.
View Photo » -
Reuters Pictures
Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, speak during a news conference announcing the merger of the two companies in New York, January 26, 2009.
View Photo » -
AP Photo
Jeffrey Kindler, left, chairman and CEO of Pfizer, and Bernard Poussot, president, chairman and CEO of Wyeth, attend a news conference Monday, Jan. 26, 2009 in New York.
View Photo » -
AP Photo
Jeffrey Kindler, left, chairman and CEO of Pfizer, and Bernard Poussot, president, chairman and CEO of Wyeth, speak at a news conference Monday, Jan. 26, 2009 in New York.
View Photo » -
AP Photo
Jeffrey Kindler, left, chairman and CEO of Pfizer, and Bernard Poussot, president, chairman and CEO of Wyeth, speak at a news conference Monday, Jan. 26, 2009 in New York.
View Photo »
AP Photo
In this Jan. 26, 2009 file photo, Jeffrey Kindler, left, chairman and CEO of Pfizer, and Bernard Poussot, president, chairman and CEO of Wyeth, speak at a news conference in New York.
View Photo »Related Topics
Related Videos
Related Conversations
There are no results for this module. Edit the module to change the search term used to query Twitter.